Norway Mrna Synthesis Raw Materials Market Size & Outlook
Related Markets
Norway mrna synthesis raw materials market highlights
- The Norway mrna synthesis raw materials market generated a revenue of USD 11.2 million in 2025 and is expected to reach USD 17.2 million by 2033.
- The Norway market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
- In terms of segment, capping agents was the largest revenue generating type in 2025.
- Capping Agents is the most lucrative type segment registering the fastest growth during the forecast period.
Mrna synthesis raw materials market data book summary
| Market revenue in 2025 | USD 11.2 million |
| Market revenue in 2033 | USD 17.2 million |
| Growth rate | 5.8% (CAGR from 2026 to 2033) |
| Largest segment | Capping agents |
| Fastest growing segment | Capping Agents |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capping Agents, Nucleotides, Plasmid DNA, Enzymes |
| Key market players worldwide | Roche Holding AG, Merck KGaA, Thermo Fisher Scientific Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, New England Biolabs, Creative-Biolabs, Jena Bioscience, YEASEN Biotechnology, BOC Sciences, Hongene Biotechnology |
Other key industry trends
- In terms of revenue, Norway accounted for 0.6% of the global mrna synthesis raw materials market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany mrna synthesis raw materials market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 198.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Synthesis Raw Materials Market Scope
MRNA Synthesis Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hongene Biotechnology | View profile | 251-500 | Shanghai, Shanghai, China, Asia | http://www.hongene.com/ |
| BOC Sciences | View profile | 501-1000 | Shirley, New York, United States, North America | https://www.bocsci.com/ |
| YEASEN Biotechnology | View profile | 501-1000 | Shanghai, Shanghai, China, Asia | http://www.lifetopstar.com/ |
| Jena Bioscience | View profile | 11-50 | Jena, Thuringen, Germany, Europe | https://www.jenabioscience.com/ |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | https://www.creative-biolabs.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Maravai LifeSciences Holdings Inc Ordinary Shares - Class A | View profile | 570 | 10770 Wateridge Circle, Suite 200, San Diego, CA, United States, 92121 | https://www.maravai.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Norway mrna synthesis raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna synthesis raw materials market will help companies and investors design strategic landscapes.
Capping agents was the largest segment with a revenue share of 39.29% in 2025. Horizon Databook has segmented the Norway mrna synthesis raw materials market based on capping agents, nucleotides, plasmid dna, enzymes covering the revenue growth of each sub-segment from 2021 to 2033.
Growing research on mRNA vaccines is anticipated to boost the mRNA synthesis raw materials to a certain extent. On the other hand, increase in research activities led to the analysis of various side affected associated with mRNA based COVID-19 vaccines such as myocarditis.
For instance, in October 2021, Norway had suspended the use of Modern COVID-19 vaccine for men younger than 30 years and all people under 18 years old because of its rare association with endocarditis and myocarditis.
Reasons to subscribe to Norway mrna synthesis raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway mrna synthesis raw materials market databook
-
Our clientele includes a mix of mrna synthesis raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway mrna synthesis raw materials market , including forecasts for subscribers. This country databook contains high-level insights into Norway mrna synthesis raw materials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Norway Type - Mrna Synthesis Raw Materials Market size, 2025 - 2033 (US$M)
Norway MRNA Synthesis Raw Materials Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
